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Control1. Introduction
This Special Issue (SI) of Food and Waterborne Parasitology focusses on zoonotic Echinococcus spp. mainly on
E. multilocularis. The invited papers can be grouped into four main topics: molecular markers of emergence, diagnostics in
both deﬁnitive and intermediate hosts, treatment of human alveolar echinococcosis (AE), and control strategies in deﬁnitive
hosts (Table 1).
E. granulosus sensu lato, the causative agent of cystic echinococcosis (CE), is a species complex with a predator – prey life cycle
mainly involving canids and herbivores, although host assemblages vary according to parasite species (Thompson, 2017). Control
of E. granulosus s.l. often depends on abattoir inspection and regulations to prevent feeding of offal to dogs, thereby breaking the
domestic cycle of those parasites. In contrast, E. multilocularis, commonly known as the small fox tapeworm, cycles in wildlife andrey@vetsuisse.unibe.ch. (C.F. Frey).
ey, Institute of Parasitology, Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University
ier Inc. on behalf of International Association of Food andWaterborne Parasitology. This is an open access article
censes/by/4.0/).
Table 1
Invited manuscripts in this Special Issue of Food and Waterborne Parasitology on zoonotic Echinococcus spp.
Section Title Authors Weblink
Molecular markers
of emergence
Genetic diversity of Echinococcus multilocularis in red foxes from
two Scandinavian countries: Denmark and Sweden
Knapp J, Umhang G, Wahlström H, Al-Sabi
MNS, Ågren EO, Enemark HL
https://doi.
org/10.1016/j.
fawpar.2019.
e00045
Diagnosis in
deﬁnitive and
intermediate
hosts
Validation of PCR-based protocols for the detection of Echinococcus
multilocularis DNA in the ﬁnal host using the Intestinal Scraping
Technique as a reference
Maksimov P, Isaksson M, Schares G, Romig
T, Conraths FJ
https://doi.
org/10.1016/j.
fawpar.2019.
e00044
A One Health systematic review of diagnostic tools for Echinococcus
multilocularis surveillance: Towards equity in global detection
Schurer JM, Nishimwe A, Hakizimana D, Li
H, Huang Y, Musabyimana JP, Tuyishime E,
MacDonald LE
https://doi.
org/10.1016/j.
fawpar.2019.
e00048
Diagnostic and follow-up performance of serological tests for
different forms/courses of alveolar echinococcosis
Gottstein B, Lachenmayer A, Beldi G, Wang
J, Merkle B, Vu XL, Kurath U, Müller N
https://doi.
org/10.1016/j.
fawpar.2019.
e00055
Treatment of
human AE
The importance of being parasiticidal… an update on drug
development for the treatment of alveolar echinococcosis
Lundström-Stadelmann B, Rufener R, Ritler
D, Zurbriggen R, Hemphill A
https://doi.
org/10.1016/j.
fawpar.2019.
e00040
Surgical treatment strategies for hepatic alveolar echinococcosis Salm LA, Lachenmayer A, Perrodin SF,
Candinas D, Beldi G
https://doi.
org/10.1016/j.
fawpar.2019.
e00050
Elevated incidence of alveolar echinococcosis in
immunocompromised patients
Lachenmayer A, Gebbers D, Gottstein B,
Candinas D, Beldi G
https://doi.
org/10.1016/j.
fawpar.2019.
e00060
Surgery versus conservative drug therapy in alveolar echinococcosis
patients in Germany – a health-related quality of life comparison
Schmidberger J, Steinbach J, Schlingeloff P,
Kratzer W, Grüner B
https://doi.
org/10.1016/j.
fawpar.2019.
e00057
Control in
deﬁnitive hosts
Praziquantel treatment of dogs for four consecutive years decreased the
transmission of Echinococcus intermedius G7 to pigs in villages in
Lithuania
Šarkūnas M, Vienažindienė Z, Alvarez Rojas
CA, Radziulis K, Deplazes P
https://doi.
org/10.1016/j.
fawpar.2019.
e00043
A systematic review and meta-analysis on anthelmintic control
programs for Echinococcus multilocularis in wild and domestic
carnivores
Umhang G, Possenti A, Colamesta V,
d'Aguanno S, LaTorre G, Boué F, Casulli A
https://doi.
org/10.1016/j.
fawpar.2019.
e00042
AE = alveolar echinococcosis.
2 C.F. Frey et al. / Food and Waterborne Parasitology 16 (2019) e00061causes the disease AE in intermediate hosts. Its ﬁnal hosts are mainly foxes and other canids, while wild rodents serve as natural
intermediate hosts (Thompson, 2017). Humans, aberrant intermediate hosts for Echinococcus spp., can only become infected by
oral ingestion of eggs shed by the ﬁnal hosts. Therefore, human infections with E. granulosus s.l. and E. multilocularis are consid-
ered to be foodborne parasitic diseases, although waterborne transmission is also possible through eggs potentially present in un-
ﬁltered surface water. Due to their detrimental impact on human health, risks associated with both parasites regularly rank very
high in comparison with other foodborne parasites (FAO/WHO, 2014; Bouwknegt et al., 2018).2. Molecular markers of emergence
Alveolar echinococcosis is restricted to and amajor concern in the northern hemisphere (Deplazes et al., 2017), where recent
expansion of the historically endemic regions can be observed (Gottstein et al., 2015; Bebezov et al., 2018; Kotwa et al., 2019).
This expansion has been documented by the ﬁnding of adult worms or their eggs in the canid ﬁnal hosts, or by identifying the
parasite in intermediate or aberrant hosts in novel regions. In North America, for example, pet dogs suffering from AE served as
sentinels of range expansion (Jenkins et al., 2012). In contrast, surveillance in wild canids revealed newly endemic regions in
Denmark and Sweden. In this special issue, Knapp and colleagues genotyped Scandinavian isolates of E. multilocularis using
the microsatellite marker EmsB. The observed low genetic variation in the Scandinavian isolates compared to a collection of
European isolates from seven endemic countries supports the relatively recent spread of E. multilocularis to Sweden and
Denmark (Knapp et al., 2019). Furthermore, it highlights the usefulness of genotyping to better understand population dynam-
ics in a seemingly uniform parasite based on morphology and sequencing of conserved regions of nuclear DNA.
3C.F. Frey et al. / Food and Waterborne Parasitology 16 (2019) e000613. Diagnosis in ﬁnal and intermediate hosts
A central pillar in the control of zoonotic Echinococcus species is the diagnosis of infection in both deﬁnitive and intermediate
hosts. While the gold standard in deﬁnitive hosts still is the recovery of adult worms, it is labor intensive, invasive and usually
involves the death of the canid host (or uncomfortable purgation methods). Newer approaches using DNA extracted from fecal
samples and various PCR protocols seem to achieve sensitivities and speciﬁcities that are comparable to the gold standard of
the intestinal scraping technique, at least for E. multilocularis, as Maksimov et al. show in their thorough study (Maksimov
et al., 2019). The possibility to screen fecal samples for the presence of Echinococcus spp. DNA will certainly facilitate more wide-
spread and less invasive epidemiological investigations.
In their excellent One Health systematic review, Schurer et al. compile a treasure of information on diagnostic tools for
E. multilocularis published in the last decade in humans, animals, and the environment (Schurer et al., 2019). Importantly, the au-
thors also included papers originally published in Chinese – a source that is not always accessible for “western” researchers. China
is the country with the most human AE cases and therefore it is important to consider original research from this vast region in
any comprehensive review; unfortunately, due to the language barrier, there are few reviews incorporating this region, and we
are proud to present one in this SI. The authors stressed that harmonization and collaboration across political boundaries is
needed to achieve a comprehensive picture of the global situation of E. multilocularis and AE. One possible approach might be
a global reference centre for zoonotic Echinococcus species, and global phylogeographic studies to better understand the signiﬁ-
cance of genetic diversity for ecology, epidemiology, and pathogenesis.
For the diagnosis of AE in humans, serology plays an important role along with imaging and histological and molecular tech-
niques. We are happy to include in this SI an extensive review on the available serological tools in a leading diagnostic centre for
AE. Gottstein and colleagues summarize the possibilities that serology offers for the diagnosis of human AE, and also give insights
on how the antibody response changes over time after successful therapy (Gottstein et al., 2019). Thus, serology has merit not
only for initial diagnosis, but also as an important and relatively inexpensive follow-up tool that provides clinicians with valuable
information on disease regression or progression.4. Treatment of human AE
Treatment of AE is based on surgical interventions combined with chemotherapy with benzimidazoles, or chemotherapy alone.
Lundström-Stadelmann and colleagues demonstrate the search for additional drugs that might overcome the major drawback of
benzimidazoles: they do not kill the parasite (i.e. they are parasitostatic), and thus therapy is often life-long and can have consid-
erable drawbacks. In their excellent review they summarize efforts to discover new, parasiticidal drugs by repurposing old drugs
(Lundström-Stadelmann et al., 2019). Quite uniquely in the world of cestode research, Lundström-Stadelmann et al. have
established an in vitro system that allows high-throughput screening of drugs and compounds. We are also honoured to offer
the insight of experienced surgeons at a Swiss referral centre for AE. Salm et al. share their valuable expertise on surgical treat-
ment of human AE while also providing an overview of the respective literature (Salm et al., 2019). From the same group orig-
inates the study on the elevated incidence of AE in immunocompromised patients, underlining the importance of an intact
immune system to ﬁght against E. multilocularis (Lachenmayer et al., 2019). Last but not least, Schmidberger and colleagues
from a German referral centre for AE assess the quality of life of AE patients after either surgery or conservative drug therapy,
and found no signiﬁcant differences between surgically or conservatively treated patients (Schmidberger et al., 2019). This may
have important implications for low resource environments where treatment options may be restricted.5. Control in deﬁnitive hosts
Deﬁnitive hosts for Echinococcus spp. are wild and domestic carnivores that shed infective eggs in their feces. Those eggs are
the sole route of infection for humans and other animals acting as intermediate or aberrant hosts (Thompson, 2017). It is there-
fore intriguing to control infection in ﬁnal hosts in order to prevent human infections or infection of livestock and pets. The study
by Šarkūnas et al. included in this SI illustrates how local eradication of E. intermedius (E. granulosus G7) can be achieved by
treating dogs every two months with praziquantel (Šarkūnas et al., 2019). The success of this intervention was facilitated by
the unique characteristics of the village setting in Lithuania – with domestic dogs as the only ﬁnal hosts, domestic pigs as inter-
mediate hosts, and traditional slaughtering seasons during which transmission occurs from pigs to dogs over a circumscribed time
period. This success story demonstrates that, despite the probable presence of a sylvatic cycle of G7 in wolves and wild boar in
Lithuania, a targeted intervention in domestic animals can signiﬁcantly reduce infection pressure for pigs, and probably also for
humans. In the case of E. multilocularis, where the sylvatic cycle dominates, interventions to reduce prevalence tend to be
much more complex. The systematic review by Umhang and colleagues on anthelmintic control programs in carnivores in en-
demic countries ﬁnds that monthly baiting of foxes with praziquantel drastically decreases the prevalence of this parasite in a
short time period (Umhang et al., 2019). However, prevalence tends to rise again to pre-intervention levels when the baiting is
stopped. The authors therefore correctly remind us that each intervention needs to have a favorable cost/beneﬁt proﬁle before
it will be widely embraced by stakeholders. Nevertheless, under some ecological circumstances (for example, on islands) such in-
terventions can profoundly reduce prevalence in intermediate hosts and probably human risk of exposure (Rausch et al., 1990).
4 C.F. Frey et al. / Food and Waterborne Parasitology 16 (2019) e000616. Conclusions
The guest editors for this SI come from Canada and Switzerland, both regions with a high prevalence of E. multilocularis (and
E. canadensis in Canada) in wildlife and in the fortunate situation of being wealthy countries. The contributions to this SI reﬂect
this to a certain extent: most studies have been conducted in western countries, and most of the studies in the SI focus on
E. multilocularis. Nevertheless, the guest editors are very much aware that echinococcosis (especially CE) is a major concern in
many developing and resource-poor regions of the world. Some diagnostic and treatment options presented in manuscripts of
this SI may not be realistic in more remote regions. However, it is our hope the innovations and new developments achieved
under favorable economic and logistic circumstances will eventually be adapted to meet the needs of more remote or resource
poor regions, and therefore help to advance the ﬁght against these neglected parasitic diseases. The proposed global reference
centre for zoonotic Echinococcus species might be a step in the right direction, which could facilitate standardization of diagnostic
testing, curate evidence-based best practices for management of human cases and control of animal cycles, and coordinate studies
taking a One Health approach to these parasites in people, pets, livestock, wildlife, and the environment.
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